XML 180 R39.htm IDEA: XBRL DOCUMENT v3.24.1
SHAREHOLDERS EQUITY (DEFICIT) (Tables)
12 Months Ended
Dec. 31, 2023
Equity [Abstract]  
Summary of Authorized Stock
The Company has authorized stock which have been designated as follows:
 
Number of Shares
Authorized
Number of Shares
Outstanding As of
December 31,
2023
Par
Value
Class A Common Stock
80,000,000
28,043,449
$0.0001
Preferred Stock
 1,000,000
 0
$0.0001
Schedule of Stock Option Activity
The balance and activity of all stock options outstanding under the 2021 Plan as of December 31, 2023, and 2022, is as follows:

 
Options
Weighted
Average
Exercise Price
Per Share
Weighted
Average
Remaining
Contractual
Term (years)
Outstanding at January 1, 2022
 613,463
$0.12
9.6
Granted
1,894,155
$0.14
Cancelled
 0
$
Exercised
 0
$
Outstanding at December 31, 2022
2,507,618
$0.14
9.4
Granted
 382,726
$8.21
Cancelled
 (313,783)
$0.22
Exercised
 (207,392)
$0.12
Outstanding as of December 31, 2023
2,369,169
$1.43
8.8
Exercisable as of December 31, 2023
2,232,117
$0.21
 
Summary of the Range of Exercise Price, Weighted Average Remaining Contractual Life, and Weighted Average Exercise Price of Stock Options Outstanding
The following table summarizes the range of exercise price, weighted average remaining contractual life (“Life”) and weighted average exercise price (“Price”) for all stock options outstanding as of December 31, 2023:

 
Options
Outstanding
Exercise Price
Shares
Life (in years)
$0.12
 160,856
7.6
$0.14
1,594,962
8.8
$0.16
 235,042
8.5
$7.21
 76,453
9.3
$8.40
 101,778
9.9
$8.52
 200,078
9.9
 
2,369,169
8.8
Summary of Weighted-Average Assumptions Used to Determine Fair Value of Stock Options The Company’s recognizes forfeitures as they occur. The fair value of stock options on the grant date was determined using the following weighted-average assumptions during the year ended December 31, 2023 and 2022:

 
For The Year Ending
December31,
 
2023
2022
Expected term
2-6
5.5-6.3
Expected volatility
30%-71%
30%
Expected dividends
None
None
Risk-free interest rate
3.6%-4.6%
1.9%-4.0%
Forfeitures
None
None
Summary of Warrant Activity
The following table is a summary of the Company’s warrant activity during the years ended December 31, 2023 and 2022:
 
Warrants
Weighted
Average
Exercise Price
Per Share
Weighted
Average
Remaining
Contractual
Term (years)
Outstanding as of January 1, 2022
29,026,000
$11.50
5
Granted
 0
 
 
Cancelled
 0
 
 
Exercised
 0
 
 
Outstanding as of December 31, 2022
29,026,000
$11.50
5
Granted
 0
 
 
Cancelled
 0
 
 
Exercised
 0
 
 
Outstanding as of December 31, 2023
29,026,000
$11.50
5
Exercisable as of December 31, 2023
29,026,000